N348i in hiv-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations

Nicolas Sluis-Cremer, Katie Moore, Jessica Radzio, Secondo Sonza, Gilda Tachedjian

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'N348i in hiv-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases